Lora H. Ellenson

10.9k total citations · 2 hit papers
108 papers, 5.5k citations indexed

About

Lora H. Ellenson is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Molecular Biology. According to data from OpenAlex, Lora H. Ellenson has authored 108 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Obstetrics and Gynecology, 44 papers in Reproductive Medicine and 37 papers in Molecular Biology. Recurrent topics in Lora H. Ellenson's work include Endometrial and Cervical Cancer Treatments (47 papers), Ovarian cancer diagnosis and treatment (43 papers) and PI3K/AKT/mTOR signaling in cancer (17 papers). Lora H. Ellenson is often cited by papers focused on Endometrial and Cervical Cancer Treatments (47 papers), Ovarian cancer diagnosis and treatment (43 papers) and PI3K/AKT/mTOR signaling in cancer (17 papers). Lora H. Ellenson collaborates with scholars based in United States, Netherlands and Italy. Lora H. Ellenson's co-authors include Ramon Parsons, Ross L. Levine, Hironori Tashiro, Kathleen R. Cho, Marian Blazes, Antonio Di Cristofano, Daphne W. Bell, Katrina Podsypanina, Edyta C. Pirog and Stephen B. Baylin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Lora H. Ellenson

100 papers receiving 5.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mutation ofPten/Mmac1in mice causes neoplasia in multiple organ systems

1999 786 citations Lora H. Ellenson et al. profile →
Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies.

1997 581 citations Hironori Tashiro, Kathleen R. Cho et al. PubMed profile →

Peers

Lora H. Ellenson

ONCOL

John I. Risinger United States

Nobuyuki Susumu Japan

Claes G. Tropé Norway

Bjørn Risberg Norway

Regina S. Whitaker United States

Patricia A. Shaw Canada

Tanja Pejović United States

Leah Prentice Canada

Julie A. DeLoia United States

Alberto Gallardo Spain

John I. Risinger United States

Lora H. Ellenson

3.2k ×1.1

1.0k ×0.6

915 ×0.6

1.6k ×1.3

ONCOL

1.7k ×1.5

Citations per year, relative to Lora H. Ellenson Lora H. Ellenson (= 1×) peers John I. Risinger

Countries citing papers authored by Lora H. Ellenson

Since Specialization

Citations

This map shows the geographic impact of Lora H. Ellenson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lora H. Ellenson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lora H. Ellenson more than expected).

Fields of papers citing papers by Lora H. Ellenson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lora H. Ellenson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lora H. Ellenson. The network helps show where Lora H. Ellenson may publish in the future.

Co-authorship network of co-authors of Lora H. Ellenson

This figure shows the co-authorship network connecting the top 25 collaborators of Lora H. Ellenson. A scholar is included among the top collaborators of Lora H. Ellenson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lora H. Ellenson. Lora H. Ellenson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Davidson, Ben, Lora H. Ellenson, Qin Zhou, et al.. (2025). Effect of substantial lymphovascular space invasion on location of first disease recurrence in surgical stage I endometrioid endometrial adenocarcinoma. International Journal of Gynecological Cancer. 35(4). 101651–101651. 1 indexed citations

Sullivan, Mackenzie W., Qin Zhou, Lora H. Ellenson, et al.. (2024). Factors associated with an inconclusive result from commercial homologous recombination deficiency testing in ovarian cancer. Cancer. 131(1). e35523–e35523. 3 indexed citations

Green, Angela, Qin Zhou, Alexia Iasonos, et al.. (2024). A phase II study of fulvestrant and abemaciclib in hormone receptor positive advanced or recurrent endometrial cancer.. Journal of Clinical Oncology. 42(16_suppl). 5511–5511. 4 indexed citations

Dopeso, Higinio, David N. Brown, Arnaud Da Cruz Paula, et al.. (2024). TROP2 as a novel target in uterine carcinosarcoma organoid models. Gynecologic Oncology. 190. S204–S204. 1 indexed citations

Shen, Sherry, Weining Ma, David N. Brown, et al.. (2023). HER2 Genetic Intratumor Heterogeneity Is Associated With Resistance to Trastuzumab and Trastuzumab Emtansine Therapy in Recurrent High-Grade Endometrial Cancer. Modern Pathology. 36(11). 100299–100299. 12 indexed citations

Weigelt, Britta, Antonio Marra, Pier Selenica, et al.. (2023). Molecular Characterization of Endometrial Carcinomas in Black and White Patients Reveals Disparate Drivers with Therapeutic Implications. Cancer Discovery. 13(11). 2356–2369. 19 indexed citations

Rios‐Doria, Eric, Olga T. Filippova, Jennifer J. Mueller, et al.. (2023). Isolated vaginal recurrence in women with stage I endometrial cancer. Gynecologic Oncology. 179. 9–15.

Dermawan, Josephine K., Sarah Chiang, Gulisa Turashvili, et al.. (2022). Expanding the molecular spectrum of gene fusions in endometrial stromal sarcoma: Novel subunits of the chromatin remodeling complexes PRC2 and NuA4/TIP60 as alternative fusion partners. Genes Chromosomes and Cancer. 62(3). 152–160. 9 indexed citations

Matías‐Guiu, Xavier, Christina Selinger, Lyndal Anderson, et al.. (2022). Data Set for the Reporting of Endometrial Cancer: Recommendations From the International Collaboration on Cancer Reporting (ICCR). International Journal of Gynecological Pathology. 41(Supplement 1). S90–S118. 14 indexed citations

10.

Boroujeni, Amir Momeni, Bastien Nguyen, Chad Vanderbilt, et al.. (2022). Genomic landscape of endometrial carcinomas of no specific molecular profile. Modern Pathology. 35(9). 1269–1278. 54 indexed citations

11.

Boroujeni, Amir Momeni, Wissam Dahoud, Chad Vanderbilt, et al.. (2021). Clinicopathologic and Genomic Analysis of TP53 -Mutated Endometrial Carcinomas. Clinical Cancer Research. 27(9). 2613–2623. 62 indexed citations

12.

Ohara, Kentaro, Kenneth Eng, Shannon Glynn, et al.. (2021). Molecular Evaluation of Low-grade Low-stage Endometrial Cancer With and Without Recurrence. International Journal of Gynecological Pathology. 41(3). 207–219. 6 indexed citations

13.

Joshi, Ayesha R., Hong Wang, Wayne Douglas, et al.. (2012). Endometrial Tumorigenesis in Pten Mice Is Independent of Coexistence of Estrogen and Estrogen Receptor α. American Journal Of Pathology. 180(6). 2536–2547. 21 indexed citations

14.

Daikoku, Takiko, Yasushi Hirota, Susanne Tranguch, et al.. (2008). Conditional Loss of Uterine Pten Unfailingly and Rapidly Induces Endometrial Cancer in Mice. Cancer Research. 68(14). 5619–5627. 191 indexed citations

15.

Wang, Hong, Ayesha R. Joshi, Garron J. Solomon, et al.. (2008). Oviduct‐specific glycoprotein is a molecular marker for invasion in endometrial tumorigenesis identified using a relevant mouse model. International Journal of Cancer. 124(6). 1349–1357. 5 indexed citations

16.

Tesfaye, Abeba, Francescopaolo Di Cello, Jöelle Hillion, et al.. (2007). The High-Mobility Group A1 Gene Up-Regulates Cyclooxygenase 2 Expression in Uterine Tumorigenesis. Cancer Research. 67(9). 3998–4004. 62 indexed citations

17.

Ellenson, Lora H. & T.‐C. Wu. (2004). Focus on endometrial and cervical cancer. Cancer Cell. 5(6). 533–538. 91 indexed citations

18.

Wu, Rong, Lin Lin, David G. Beer, et al.. (2003). Amplification and Overexpression of the L-MYC Proto-Oncogene in Ovarian Carcinomas. American Journal Of Pathology. 162(5). 1603–1610. 48 indexed citations

19.

Schwartz, Donald R., Sharon L. R. Kardia, Kerby Shedden, et al.. (2002). Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas.. PubMed. 62(16). 4722–9. 348 indexed citations

20.

Lax, Sigurd, Brian Kendall, Hironori Tashiro, Robbert J.C. Slebos, & Lora H. Ellenson. (2000). The frequency of p53, k-ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma. Cancer. 88(4). 814–824. 350 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact